Physician profile
Mark R Izzo
NPI 1811975584
$6,469.23
in general payments reported to CMS, 2019-2025
26 companies · $1,897 in 2025
The $1,897 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $176 · 2021: $781 · 2022: $788 · 2023: $763 · 2024: $1,492 · 2025: $1,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,152.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,843.43 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $1,666.97 | 2021-2024 | Impella |
| Boston Scientific Corporation | $843.30 | 2019-2024 | Watchman Flx |
| Medtronic, INC. | $643.39 | 2022-2025 | Symplicity G3, Resolute Onyx, Venaseal |
| Inari Medical, INC. | $464.00 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Recor Medical INC | $141.09 | 2024 | Paradise Renal Denervation System |
| Livanova USA, INC. | $131.42 | 2021 | |
| Abbott Laboratories | $118.95 | 2022-2025 | Xience Skypoint |
| Shockwave Medical, INC | $104.25 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $94.51 | 2023-2025 | Ffrct |
| Medtronic Vascular, INC. | $61.26 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $59.40 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.42 | 2022-2024 | Eliquis |
| Pfizer INC. | $42.51 | 2019-2023 | |
| Ekos Corporation | $32.01 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $29.98 | 2021 | |
| Cardiovascular Systems INC. | $26.97 | 2022 | |
| Irhythm Technologies, INC. | $22.05 | 2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $18.49 | 2025 | Revcore Thrombectomy Catheter |
| Amarin Pharma, INC. | $18.05 | 2021 | |
| Novo Nordisk INC | $15.80 | 2025 | |
| Amgen INC. | $15.29 | 2020 | |
| Cardinal Health 200 LLC | $11.37 | 2020 | |
| W. L. Gore & Associates, INC. | $11.32 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Izzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.